Dr. Sudhir Gorukanti leads Research & Development for Granules Pharmaceuticals Inc., overseeing formulation development and product innovation across the organization’s pharmaceutical portfolio.
With more than 25 years of experience in drug delivery and pharmaceutical product development, he has successfully guided numerous products from early-stage formulation through ANDA submission and commercial launch. Prior to joining Granules, Dr. Gorukanti held senior R&D leadership positions at Hikma Pharmaceuticals, Mayne Pharma, Actavis, Aurobindo Pharma, Teva Pharmaceuticals, Barr Laboratories, and Pfizer.
Education: Bachelor of Pharmacy, Kakatiya University; M.S. and Ph.D. in Pharmaceutical Sciences, St. John’s University; Global C-Suite Program, The Wharton School.